SGO 2023 Conference Coverage on VuMedi

 

SGO 2023 Conference Coverage on VuMedi
B

SGO 2023 Phase 1 Trial of Botensilimab + Balstilimab in Patients With Recurrent Platinum Refractory/Resistant Ovarian Cancer

By SGO 2023 Conference Coverage on VuMedi FEATURING Bruno Bockorny
By SGO 2023 Conference Coverage on VuMedi FEATURING Bruno Bockorny
0 views
April 14, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

19:30
AstraZeneca Oncology

The Importance of HRD Testing in Advanced Ovarian Cancer

Feat. M. Markman

Featured Video

17:33
AstraZeneca Oncology

First-line Maintenance Therapy for BRCAm Advanced Ovarian Cancer Fol…

Feat. S. Lewin
Videos
04:53
SGO 2023 Conference Coverage on VuMedi

SGO 2023 Updates on Advanced or Recurrent Endometrial Tumors: NGS Co…

Feat. S. Lee
07:23
SGO 2023 Conference Coverage on VuMedi

SGO 2023 Phase 1 Trial of Botensilimab + Balstilimab in Patients Wit…

Feat. B. Bockorny
11:32
SGO 2023 Conference Coverage on VuMedi

SGO 2023 GOG 3026 Phase II Trial of Letrozole + Ribociclib in Women …

Feat. B. Slomovitz
11:01
SGO 2023 Conference Coverage on VuMedi

Molecular Classification of Mixed Histology Endometrial Cancers

Feat. P. Haight
06:48
SGO 2023 Conference Coverage on VuMedi

SGO 2023 Phase 3 UP-NEXT Trial: Upifitamab Rilsodotin, a NaPi2b-Dire…

Feat. D. Richardson
11:02
SGO 2023 Conference Coverage on VuMedi

Chemoradiation for Stage IB3 Cervical Cancer

Feat. J. Mayadev
11:14
SGO 2023 Conference Coverage on VuMedi

SGO 2023 Placebo-Controlled Randomized Phase 3 Trial: Dostarlimab in…

Feat. M. Raza Mirza
09:07
SGO 2023 Conference Coverage on VuMedi

SGO 2023 Primary Ovarian Cancer Patients: Health-Related Quality of …

Feat. V. Gushchin
06:09
SGO 2023 Conference Coverage on VuMedi

SGO 2023 Sentinel Lymph Biopsy vs. Full Lymphadenectomy in Endometri…

Feat. C. Nahshon